Page last updated: 2024-12-06

2,7-dinitrofluorenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,7-Dinitrofluorenone is a bright yellow solid compound with the formula C13H6N2O5. It is a versatile reagent that can be used in a variety of organic reactions. 2,7-Dinitrofluorenone is synthesized by the nitration of fluorenone. It is known to be a strong electron-withdrawing group and is often used in the synthesis of dyes, polymers, and pharmaceuticals. It is also used as a reagent in the preparation of other organic compounds. 2,7-Dinitrofluorenone is of interest in organic chemistry research because of its unique properties and its potential applications in various fields.'

2,7-dinitrofluorenone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID35842
CHEMBL ID424175
SCHEMBL ID1237207
MeSH IDM0107936

Synonyms (45)

Synonym
9h-fluoren-9-one, 2,7-dinitro-
7239-14-7
nsc86561
9h-fluoren-9-one,7-dinitro-
2,7-dinitrofluoren-9-one
2,7-dinitro-9-fluorenone
nsc-86561
fluoren-9-one,7-dinitro-
31551-45-8
2,7-dinitrofluorenone
9-fluorenone, 2,7-dinitro-
nsc 86561
ccris 2911
brn 1994019
fluoren-9-one, 2,7-dinitro-
einecs 250-695-1
SR-01000643024-1
STK290998
OPREA1_707607
2,7-dinitro-9-fluorenone, 97%
D1396
MAYBRIDGE1_004322
2,7-dinitro-9h-fluoren-9-one
HMS553M12
CHEMBL424175 ,
AKOS003237995
BBL002471
CCG-53894
r33rll32yx ,
unii-r33rll32yx
FT-0610754
AKOS015912847
SCHEMBL1237207
bdbm50134202
DTXSID4025163
mfcd00001153
J-018460
VS-01080
A854292
D89850
2,7-dinitrofluorenon
dinitro-9h-fluoren-9-one, 2,7-
9-oxo-2,7-dinitrofluorene
CS-0312855
SY112048
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID780353Inhibition of telomerase (unknown origin) at 10 uM TRAP assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1264000Inhibition of rat UT-A1 expressed in MDCK-UT-A1-AQP1-YFP cells after 15 mins by fluorescence assay
AID1264001Inhibition of UT-B in rat whole blood after 15 mins by RBC lysis assay
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID780422Cytotoxicity against human PC3 cells after 48 hrs by sulforhodamine B assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]